Pharma Marketing Network

JANUARY 16, 2025

Upcoming Informa Connect Events: Clinical Data Disclosure, Transparency and Plain Language Summaries February 25-26, 2025 Speaker Programs Summit March 3-5, 2025 Rare Disease Summit March 18-20, 2025 PAP Patient Assistance & Access Programs March 18-20, 2025 Hub and Specialty Pharmacy Models East March 18-20, 2025 Pharma Forum March 23-26, 2025 (..)

Specialty Pharmacies 40

Specialty Pharmacies Compounding Pharmacies Compounding 40

Pharma Marketing Network

JANUARY 16, 2025

Upcoming Informa Connect Events: Clinical Data Disclosure, Transparency and Plain Language Summaries – February 25-26, 2025 Speaker Programs Summit – March 3-5, 2025 Rare Disease Summit – March 18-20, 2025 PAP Patient Assistance & Access Programs – March 18-20, 2025 Hub and Specialty Pharmacy Models East – March 18-20, (..)

Specialty Pharmacies 40

Specialty Pharmacies Compounding Pharmacies Compounding 40

PharmD Live

JANUARY 15, 2025

The Centers for Medicare & Medicaid Services (CMS) has announced a 2.83% reduction in the Medicare Physician Fee Schedule (PFS) for 2025. Key Points of the 2025 PFS Reduction The 2025 PFS introduces a reduced conversion factor of $32.35, down from $33.29

Medication Therapy Management (MTM) 64

Medication Therapy Management (MTM) Hospitals Compounding 64

pharmaphorum

NOVEMBER 9, 2022

Sanofi has tapped into the artificial intelligence expertise of Chinese biotech Insilico Medicine with a six-compound drug discovery collaboration that could be worth up to $1.2 The alliance is backloaded, with $21.5 Currently, the time needed for a drug to reach the market ranges from 12 to 18 years, with an average cost of about $2.6

Compounding 111

Compounding Drug Development 111

PhRMA

FEBRUARY 5, 2025

One of the largest compounders in the U.S., Hims & Hers, is spending millions of dollars to run a misleading Super Bowl ad that misrepresents their unapproved GLP-1 medicines.

Compounding 40

Compounding 40

FDA Law Blog: Biosimilars

SEPTEMBER 11, 2024

FDA says that highly potent compounds – again, as defined in ICH M7(R2) – pose risks below that limit. The revisions due in 2025 include testing for NDSRIs. Using the guidelines found in the ICH M7(R2) , FDA set an AI threshold of 1.5 We note that the other FDA guidance document on nitrosamines addresses NDSRIs.

Documentation 105

Documentation Compounding 105

Outsourcing Pharma

JUNE 20, 2023

A small molecule compound has shown to induce strong anti-tumor immune responses â an area where medical need is high.

Compounding 52

Compounding Immunization Immunity 52

Express Pharma

JANUARY 11, 2024

The sales growth of gout therapies across the seven major markets (7MM: the US, 5EU, and Japan) is set to increase at a compound annual growth rate (CAGR) of 8.8 per cent from $4.6 billion in 2022 to $10.8 billion in 2032, in line with the steadily increasing disease prevalence and the entrance of novel agents, according to GlobalData.

Biosimilars 103

Biosimilars Compounding 103

pharmaphorum

AUGUST 17, 2022

The deal will see Atomwise identify, synthesize, and advance lead compounds for up to five drug targets that will then be exclusively Sanofi’s to develop. A recent report from GlobalData predicted that pharma spending on AI drug discovery would hit $3 billion in 2025.

Compounding 97

Compounding Drug Development 97

Pharmaceutical Business Review

DECEMBER 20, 2024

Assembly Bio CEO and president Jason Okazaki said: Gileads further investment strengthens our balance sheet as we look ahead to multiple key clinical data readouts for our novel antiviral candidates in 2025. In addition, we expect our updated clinical plan for ABI-6250 to significantly reduce the development timeline for the compound.

Compounding 52

Compounding 52

Express Pharma

NOVEMBER 2, 2023

Against this backdrop, the CD drug sales across the eight-major markets (8MM*) are set to increase at a compound annual growth rate (CAGR) of 4.7 The anticipated launches in the US and Europe of Janssen’s Tremfya (guselkumab) and Lilly’s mirikizumab, in Q4 2025 and Q3 2026, respectively, are expected to shape the market.

Biosimilars 100

Biosimilars Compounding 100

Express Pharma

AUGUST 17, 2023

million by 2025. Globally, the systemic antibacterial market, which is growing at a compounded annual growth rate of 4.26 The launch of Elores in Oman is expected to open the doors for the entry of the novel antibiotic adjuvant entity in other important Gulf Cooperation Council (GCC) member countries as well. “

Compounding 98

Compounding 98

FDA Law Blog: Biosimilars

DECEMBER 3, 2023

On November 17th, CMS issued its final guidance on the Discount Program in which it responded to public comments and provided updated guidance for the Discount Program for 2025 and 2026. Manufacturers must sign the agreement by March 1, 2024, to participate in the 2025 plan year. Final Guidance at 2.

Labelling 105

Labelling Drug Pricing Compounding Payment Processing 105

Express Pharma

JUNE 5, 2023

billion in 2031 across the 8MM, registering a compound annual growth rate (CAGR) of 1.9 Constellation Pharmaceuticals’ BET inhibitor pelabresib is also set to gain FDA approval in 2025, straight into the first-line setting in combination with Jakafi with the view to improve clinical responses from day 1 of therapy.

Drug Development 97

Drug Development Biosimilars Compounding 97

Express Pharma

MARCH 22, 2024

billion by 2025 and approach $84.44 This slow response mechanism further compounds issues Report merging delays: After trials, coordinating for reports across departments becomes a herculean task, delaying the final report dispatch to patrons. By 2020, out of the mammoth $200 billion pumped into pharma research, a whopping $48.4

Compounding 105

Compounding 105

Express Pharma

OCTOBER 16, 2024

The CRO sector in India, growing at a compound annual growth rate (CAGR) of 10.75 Courtesy of contract research organisations (CROs), contract manufacturing organisations (CMOs), and contract development and manufacturing organisations (CDMOs), India’s life sciences sector is rising steadily. per cent, is projected to reach $2.5

Biosimilars 103

Biosimilars Compounding Pharmaceutical Companies Pharmaceutical Companies 103

pharmaphorum

APRIL 7, 2022

Sandoz and Ares – a subsidiary of OpGen – started working together in 2018, and with the extension will continue the project until the end of January 2025. “AMR, which is now estimated to directly account for nearly 1.3 The post Sandoz, Ares extend digital alliance on antimicrobial resistance appeared first on.

Compounding 52

Compounding 52

pharmaphorum

OCTOBER 10, 2022

The global digital health market is expected to make a compound annual growth rate of almost 25% from 2019 to 2025. Although the health technology industry is experiencing a funding lull right now, the current climate won’t last forever.

Compounding 111

Compounding Hospitals 111

pharmaphorum

JULY 22, 2022

In 2025, the global cleanroom technology market is expected to reach nearly $5 billion. View the brochure and to download visit [link]. The post 2nd Annual Next Generation Pharmaceutical Cleanrooms Conference appeared first on.

Compounding Pharmacies 52

Compounding Pharmacies Compounding 52

Pharmaceutical Technology

OCTOBER 31, 2022

billion in 2031, at a compound annual growth rate (CAGR) of 4.4%. Two categories of novel therapies stand out: cell therapies and therapies with novel MOAs, with new products in each category being forecast to launch between 2023 and 2025. The osteoarthritis (OA) market was valued at $2.5 of the 7MM sales, respectively.

Compounding 59

Compounding Pharmaceutical Companies Pharmaceutical Companies 59

RX Note

APRIL 8, 2023

Although the next review date is set for December 2025, a lot can happen in 5 years. Rather than just publishing an eBook, I wished Ministry of Health can create a website or mobile application with continuous database updates to keep up with new drugs and changes.

Compounding 52

Compounding Hospitals 52

The Thyroid Pharmacist

NOVEMBER 29, 2023

These don’t expire until 2025, but they are also on sale: Cat’s Claw AV – Cat’s Claw AV contains herbs and nutrients known for supporting a healthy inflammatory response and immune system. We have 270 expiring in March 2025.) We have 299 expiring in March 2025.) We have 290 expiring in April 2025.)

Health and Personal Care Stores 73

Health and Personal Care Stores Immunity Immunization Labelling 73

pharmaphorum

OCTOBER 12, 2022

A recent GlobalData report predicted that the industry’s annual spend on AI will reach $3 billion by 2025, fuelled by a lengthening list of AI-based drug discovery strategic alliances that swelled from 10 in 2015 to 105 last year.

Compounding 64

Compounding 64

pharmaphorum

JANUARY 10, 2023

Approximately 30% of global data volume is generated by the healthcare industry and it will continue to expand with a compound annual growth rate predicted to reach 36% by 2025, according to research by RBC Capital Markets.

Compounding 98

Compounding Communication Pharmaceutical Companies Pharmaceutical Companies 98

pharmaphorum

AUGUST 19, 2022

The drug works via the same target as capsaicin, a compound found in chilli peppers that is used in some topical formulations for pain relief in arthritis and other conditions, but is much more potent. If all goes well, the aim is to bring resiniferatoxin to market in 2025.

Diabetes 52

Diabetes Compounding 52

Express Pharma

SEPTEMBER 24, 2023

billion by 2029, reflecting a robust 55 per cent compound annual growth rate (CAGR). PCN-101, a small-molecule drug that is indicated for treatment-resistant depression, is expected to launch in the US in December 2025 and is forecast to generate $1.6 billion in sales in 2029. billion in sales in 2029.

Drug Development 52

Drug Development Compounding 52

Quality Matters

AUGUST 29, 2023

According to the new guidance, confirmatory testing for approved products should be completed by August 1, 2025. By this date, “manufacturers and applicants should ensure that any NDSRIs in their drug products meet the FDA-recommended AI limit.”

Compounding 52

Compounding 52

Quality Matters

MARCH 1, 2024

USP has a long-standing history of healthcare standards including those for compounding preparations that are tailored to meet the unique needs of patients who may not otherwise have access to their medications. In the meantime, USP encourages interested parties to reach out for more information as USP approaches its new 2025-2030 cycle.

Labelling 52

Labelling Compounding 52

Pharmaceutical Technology

JUNE 19, 2023

Further compounding the complexity is the highly temperature-sensitive nature of these products, meaning any hiccup faced when processing products outside of their freezer banks can have a serious, knock-on effect.

Packaging 52

Packaging Compounding Communication Pharmaceutical Companies 52

Express Pharma

JULY 10, 2024

Brimming with potential As per an Invest India report of 2023, the Indian Bioeconomy, valued at $137 billion in 2023, is targeted to reach $150 billion by 2025 and $300 billion by 2030. IBER Report 2023 divulges, “The biopharma vaccines (non-COVID alone) market makes a significant daily contribution of approximately $38 million.

Vaccines 96

Vaccines Drug Development Process Improvement Biosimilars 96

Viseven

MARCH 6, 2023

billion by 2025 , with a compound annual growth rate (CAGR) growth of more than 9%. Such a massive number of patients require a more advanced approach regarding patient relationships and how to manage them. The market researchers expect the healthcare CRM market size to reach $17.8 Let’s go.

Communication 52

Communication HIPAA Customer Service Hospitals 52

Viseven

AUGUST 29, 2024

Although 5G is currently limited to large cities in developed countries, by around 2025, we can expect its reach will extend beyond the urban areas. trillion, with a compound annual growth rate (CAGR) of 35.7%. Its technical advantages over 4G are evident – handling more connections at speeds up to 100 times faster.

Communication 52

Communication Hospitals Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

DECEMBER 6, 2022

The power of AI is also being harnessed to sift through vast amounts of data to determine potential areas of treatment or to discover new uses for old compounds. The research programme was officially launched at the end of October 2022, and has the aim of building a resource of five million individuals’ information by 2025.

Medical Records 98

Medical Records Compounding Diabetes Immunity 98

STAT

DECEMBER 2, 2024

These medicines, called radiopharmaceuticals or radioligand therapies, fuse radioactive isotopes with a targeting component that will guide the compound to cancer cells like a missile, ideally obliterating the diseased cells and leaving the surrounding area relatively unscathed.   Continue to STAT+ to read the full story…

Compounding 345

Compounding Pharmaceutical Companies Pharmaceutical Companies Drug Development 345

Pharmaceutical Technology

MARCH 22, 2023

From 2025, it will be substituted with a new chapter on functional tests for the complete system.” When it comes to highly sensitive large-molecule drugs, sourcing premium elastomeric components with a cleaner compound, such as Datwyler’s FM457, is an essential step in reducing the E&L risk.

Packaging 52

Packaging Compounding Pharmaceutical Companies Pharmaceutical Companies 52

Express Pharma

JANUARY 15, 2025

Indias leading B2B events organiser, Informa Markets in India, is set to host the 3rd edition of Vitafoods India from February 5th to 7th 2025 at Pavilion 1-2, Jio World Convention Center, Mumbai. With Indias nutraceutical market projected to grow from USD 4 billion in 2020 to USD 18 billion by 2025, with a CAGR of 13.6

Labelling 105

Labelling Immunity Immunization Compounding 105

Pharmaceutical Technology

FEBRUARY 23, 2023

billion by 2025. The recent Covid-19 pandemic compounded this issue, with many health providers facing extreme back-logs and a greater fear of mortality in the general public. Social media plays a massive role in all aspects of our lives with regular users expected to grow to approximately 4.4

Hospitals 111

Hospitals Compounding 111